# SEG Owner Medical Closure Decision Record

**Document ID:** `SEG_OWNER_MEDICAL_CLOSURE_DECISION_RECORD`  
**Mode:** `OWNER GOVERNED MEDICAL REVIEW`  
**Review pathway:** `OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY`  
**Decision authority:** Dr. Alaa Al-Asfar — SEG Medical Content Owner; Emergency Medicine Physician; Project Lead  
**Decision-record timestamp:** `2026-08-22T15:17:44+00:00` — observed execution timestamp; not a substitute for missing source-review dates  
**Scope:** Drug HTML, OSCE Atlas package, and PreTest content artifacts

## 1. Decision boundary

This record documents an owner-governed closure decision using only the evidence presently recorded for the three declared `SEG_INTERNAL_ASSET` scopes. It distinguishes limited acceptance for controlled internal development from clinical validation, source approval, rights clearance, normalization readiness, or production release.

The owner decision for each source is `OWNER_REQUIRES_FURTHER_REVIEW`. This means that the retained artifact may remain available for controlled governance work and evidence closure, but the source has not completed the required clinical, quality, provenance, rights, metadata, accessibility, or technical gates. No source is approved or ready for normalization.[1] [2]

## 2. Source decision summary

| Source | Reviewed scope | Accepted elements for restricted internal development | Remaining limitations | Required future actions | Owner decision |
|---|---|---|---|---|---|
| Drug HTML | Locked HTML identity/hash, structural field inventory, internal metadata definition, clinical-field requirements, and Drug Safety review requirements | Retained artifact continuity, non-clinical structural observations, internal governance identifier, and controlled evidence/review preparation only | Canonical source/version, provenance, rights, track/taxonomy, clinical field completeness, drug safety, metadata disposition, technical lineage, and dated review evidence remain open | Complete owner-governed Emergency Medicine, Pharmacology/Drug Safety, metadata, technical, rights/provenance, and audit reviews against the unchanged hash | `OWNER_REQUIRES_FURTHER_REVIEW` |
| OSCE Atlas | Locked package identity/hashes, archive integrity, 14-PNG inventory and hashes, technical inventory, labeling/accessibility requirements, and provenance/rights gaps | Recovered package continuity, inventory evidence, and controlled per-image review preparation only | Canonical atlas identity/version, per-image lineage, rights, clinical educational suitability, labeling, full visual review, accessibility, technical review, and dated findings remain open | Complete per-image review for all 14 members, clinical/educational and visual/accessibility reviews, source/lineage/rights closure, and audit dispositions | `OWNER_REQUIRES_FURTHER_REVIEW` |
| PreTest | Locked `UPD811-007` representation/hash, documented OCR issue, reconciliation checklist, question-inventory requirements, and answer/explanation validation requirements | Retained representation continuity and controlled reconciliation/review preparation only; no question or answer content accepted as clinically validated | Authoritative source, OCR comparison, question completeness/numbering, answer-key and explanation evidence, provenance, rights, assessment quality, and dated review evidence remain open | Recover authoritative source, complete read-only reconciliation, then complete owner-governed Emergency Medicine, Assessment Quality, technical/OCR, metadata, rights/provenance, and audit reviews | `OWNER_REQUIRES_FURTHER_REVIEW` |

The accepted elements in this table are governance and evidence-handling dispositions only. They are not acceptance of the medical claims, diagnoses, doses, labels, questions, answers, explanations, or images as clinically correct.

## 3. Drug HTML decision

### 3.1 Reviewed scope

The reviewed scope covers the locked artifact `LOCAL_INTAKE_ARTIFACT` at `/home/ubuntu/upload/deepseek_html_20260615_a3266b.html`, 25,918 bytes, 394 lines, SHA-256 `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac`. It includes the recorded structural inventory of 19 `summaryData` sections, 21 `quick` entries, 47 `drugList` entities, and 20 `trapsList` entries, together with the internal metadata definition and the required clinical/drug-safety review domains.[3]

### 3.2 Accepted elements

For controlled internal development and governance work only, the owner accepts the retained artifact reference, its hash-linked continuity, the non-clinical structural inventory, and the internal representation identifier `SEG-P0-DRUG-HTML-LOCAL-INTAKE-001` as review anchors. This limited disposition does not accept the clinical contents, drug doses, interactions, contraindications, safety statements, or emergency-medicine relevance.

### 3.3 Remaining limitations

The canonical source identity, publisher/custodian, source version/edition/date, original locator, extraction history, complete provenance, rights/display scope, professional track/taxonomy, entity-level clinical fields, safety/currency evidence, technical lineage review, and attributable dated Emergency Medicine and Pharmacology/Drug Safety decisions remain unresolved. The absence of an observed pairwise interaction table is an artifact observation only and is not evidence that interactions are absent.

### 3.4 Required future actions

The next review must examine each applicable entity and section for identity, formulation, dose/units, administration, contraindications, precautions, interactions, adverse effects, monitoring, emergency relevance, currency, citations, and exact locators. A separate metadata, technical/lineage, rights/provenance, and audit disposition must be recorded. No medication fact may be silently corrected or added through this decision record.

**Owner decision:** `OWNER_REQUIRES_FURTHER_REVIEW`.

## 4. OSCE Atlas decision

### 4.1 Reviewed scope

The reviewed scope covers `ATLAS_ASSET_OSCE_VISUAL_001`, the recovered package `OSCE_Emergency_Medicine_Imaging_Section_Package.zip`, inner SHA-256 `ca5a7f5713bf5101daa839a546633366d7b5b876604bd3dbf7cea2972d59f66e`, outer recovery-container SHA-256 `8182d243fc762e29efba5adeda4233042f5e337846b3fbe819fcd374ef948758`, and the 14 PNG members listed in the closure-status record. The review scope includes package continuity, image inventory, clinical-label requirements, accessibility requirements, provenance/rights gaps, and the need for member-level decisions.[4]

### 4.2 Accepted elements

For controlled internal development and governance work only, the owner accepts the recovered package continuity, archive integrity, exact 14-member inventory, member hashes, and defined per-image review scope as review anchors. This limited disposition does not accept the images as clinically relevant, correctly labeled, visually adequate, accessible, educationally suitable, or cleared for display or redistribution.

### 4.3 Remaining limitations

The authoritative atlas identity/title, creator/owner/custodian, version/date, original locator, source-to-image and source-to-text lineage, transformation history, per-image rights, complete station mapping, clinical educational suitability, labeling accuracy, full 14-image visual review, alt-text/equivalent access, assistive-technology behavior, technical review, and attributable dated decisions remain unresolved. The PNG set must remain separate from the Clinical Images source family.

### 4.4 Required future actions

Each of the 14 PNG members requires a separate review disposition tied to its exact filename, hash, package locator, and station/source locator. The owner-governed review must assess image relevance, visible clinical features, captions/context, orientation/laterality, annotation semantics, uncertainty, visual quality, contrast, non-color dependence, alt-text or equivalent access, long descriptions when required, reading order, language clarity, and assistive-technology behavior. Rights and provenance must be reviewed separately. No image, caption, label, alt-text, or station text may be changed through this decision record.

**Owner decision:** `OWNER_REQUIRES_FURTHER_REVIEW`.

## 5. PreTest decision

### 5.1 Reviewed scope

The reviewed scope covers registry reference `UPD811-007`, `pretestnew_Study_Guide_UTF8.txt`, 131,490 bytes, 1,349 logical lines, SHA-256 `b4ba84879b1247b9aaeb6172c6dffcb7dcc0860f8894e4651b2bc8a9fd669166`. It includes the documented OCR/extraction issue, reconciliation checklist, unresolved question-inventory status, and answer/explanation validation requirements.[5]

### 5.2 Accepted elements

For controlled internal development and governance work only, the owner accepts the retained representation, its hash-linked continuity, the recorded OCR issue register, and the defined reconciliation workflow as review anchors. This limited disposition does not accept the questions, options, answers, explanations, numbering, clinical claims, or assessment value as correct or complete.

### 5.3 Remaining limitations

The authoritative `pretestnew.pdf` or independently verifiable equivalent, canonical source identity/version/date/locator, immutable source-to-text comparison, OCR discrepancy classification, question count/completeness/numbering baseline, answer-key inventory, explanation/rationale inventory, provenance, rights, track/taxonomy, and attributable dated Emergency Medicine and Assessment Quality decisions remain unresolved. The 1,349-line count must not be treated as a question count.

### 5.4 Required future actions

The authoritative representation must be obtained or recovered and preserved alongside the current text without overwrite. A read-only comparison must classify substitutions, omissions, additions, truncation, duplication, ordering changes, numbering conflicts, and impacts to negation, units, symbols, options, answers, explanations, or clinical meaning. Every question must then be mapped to the answer key and explanation/rationale, with exact locators and unresolved issues retained. No OCR character, question, answer, explanation, numbering, or clinical claim may be invented or silently corrected.

**Owner decision:** `OWNER_REQUIRES_FURTHER_REVIEW`.

## 6. Decision controls

The owner decision is an internal governance disposition for the declared asset scopes. It does not create external approval, copyright clearance, clinical publication approval, or learner-facing authorization. It does not change the Source Registry or any schema, database, application, or content structure.

```text
INTERNAL_REVIEW_MODEL = OWNER_GOVERNED_MEDICAL_REVIEW_PATHWAY
OWNER_DECISION_ALL_P0 = OWNER_REQUIRES_FURTHER_REVIEW
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
READY_FOR_NORMALIZATION = NOT_SET
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
CONTENT_MODIFIED = FALSE
```

| Non-action | Result |
|---|---|
| External approval claimed | `NO` |
| Copyright/rights clearance claimed | `NO` |
| Clinical correctness certified | `NO` |
| Clinical publication or production approval claimed | `NO` |
| Source approval granted | `NO` |
| Normalization performed | `NO` |
| Content imported, activated, or published | `NO` |
| Database/schema/application changed | `NO` |
| Source content corrected or rewritten | `NO` |

## 7. Next allowed phase

The next allowed phase is completion of the outstanding owner-governed review domains and evidence gates against the exact immutable artifacts. The required records must contain an attributable identity or owner-executed authority, appropriate role/qualification evidence where supplied, actual review date/time, exact hash and locators, findings, conflicts, unresolved issues, disposition, limitations, and append-only audit linkage.

A future owner decision may be reconsidered only from new, attributable evidence. This record itself does not permit normalization, Content Record creation, database or schema changes, import, activation, publication, or learner exposure.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_OWNER_REVIEW_AUTHORITY_POLICY.md "SEG Owner Review Authority Policy"

[2]: file:///home/ubuntu/seg-internship-output/SEG_P0_APPROVAL_GATE_CRITERIA.md "SEG P0 Approval Gate Criteria"

[3]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_CLOSURE_STATUS.md "SEG Drug HTML Closure Status"

[4]: file:///home/ubuntu/seg-internship-output/SEG_OSCE_ATLAS_CLOSURE_STATUS.md "SEG OSCE Atlas Closure Status"

[5]: file:///home/ubuntu/seg-internship-output/SEG_PRETEST_CLOSURE_STATUS.md "SEG PreTest Closure Status"

[6]: file:///home/ubuntu/seg-internship-output/SEG_P0_AUDIT_TRAIL_REGISTER.md "SEG P0 Audit Trail Register"

**Document status:** `OWNER_MEDICAL_CLOSURE_DECISION_RECORDED_ALL_P0_REQUIRE_FURTHER_REVIEW`
